|
| 37454202 | Actionability classification of variants of unknown significance correlates with functional effect. | NPJ Precis Oncol | 2023 |
| 35138907 | A functional genomic approach to actionable gene fusions for precision oncology. | Sci Adv | 2022 |
| 34108622 | Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. | Oncogene | 2021 |
| 34638434 | <i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. | Cancers (Basel) | 2021 |
| 34779417 | Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. | J Clin Invest | 2021 |
| 34507989 | Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases. | Proc Natl Acad Sci U S A | 2021 |
| 34117033 | Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer. | Clin Cancer Res | 2021 |
| 32540409 | Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations. | J Thorac Oncol | 2020 |
| 32079540 | Comprehensive assessment of computational algorithms in predicting cancer driver mutations. | Genome Biol | 2020 |
| 29533785 | Systematic Functional Annotation of Somatic Mutations in Cancer. | Cancer Cell | 2018 |
| 30096302 | Comprehensive Characterization of Cancer Driver Genes and Mutations. | Cell | 2018 |
| 30012111 | AKT isoform-specific expression and activation across cancer lineages. | BMC Cancer | 2018 |
| 30389923 | Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. | Nat Commun | 2018 |
| 30380420 | Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. | Cell Rep | 2018 |
| 29353445 | Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis. | Dig Dis Sci | 2018 |
| 29625053 | Comprehensive Characterization of Cancer Driver Genes and Mutations. | Cell | 2018 |
| 29738578 | Cancer driver mutation prediction through Bayesian integration of multi-omic data. | PLoS One | 2018 |
| 28528867 | A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. | Cancer Cell | 2017 |
| 28500277 | Ba/F3 transformation assays. | Oncotarget | 2017 |
| 28202507 | YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway. | Cancer Res | 2017 |
| 28984208 | Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. | BMC Genomics | 2017 |
| 28566428 | Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers. | Sci Transl Med | 2017 |
| 26979494 | Transcriptome analysis of different developmental stages of amphioxus reveals dynamic changes of distinct classes of genes during development. | Sci Rep | 2016 |
| 25546157 | RET fusion as a novel driver of medullary thyroid carcinoma. | J Clin Endocrinol Metab | 2015 |
| 25629879 | Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome Atlas. | Nat Commun | 2015 |
| 25445830 | The draft genome, transcriptome, and microbiome of Dermatophagoides farinae reveal a broad spectrum of dust mite allergens. | J Allergy Clin Immunol | 2015 |
| 24395800 | Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. | Proc Natl Acad Sci U S A | 2014 |
| 25284480 | Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors. | Cancer Cell | 2014 |
| 25193510 | A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma. | Mol Cancer Ther | 2014 |
| 24871328 | A pan-cancer proteomic perspective on The Cancer Genome Atlas. | Nat Commun | 2014 |
| 22565394 | Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines. | Invest New Drugs | 2013 |
| 23619167 | Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. | Cancer Discov | 2013 |
| 23169799 | Identification of small RNAs in Mycobacterium smegmatis using heterologous Hfq. | RNA | 2013 |
| 23229819 | p63 regulates cell proliferation and cell cycle progressionâ¿¿associated genes in stromal cells of giant cell tumor of the bone. | Int J Oncol | 2013 |
| 23347832 | Full-length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cells. | FEBS Lett | 2013 |
| 23284286 | Insertion/deletion polymorphisms in the οNp63 promoter are a risk factor for bladder exstrophy epispadias complex. | PLoS Genet | 2012 |
| 20886653 | Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone. | J Orthop Res | 2011 |
| 21814558 | The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. | PLoS One | 2011 |
| 21540083 | Characterization of human FHL2 transcript variants and gene expression regulation in hepatocellular carcinoma. | Gene | 2011 |
| 21377781 | FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. | Cancer Lett | 2011 |
| 21119603 | FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation. | Oncogene | 2011 |
| 21057531 | Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death. | Oncogene | 2011 |
| 21130852 | The involvement of N-G,N-G-dimethyarginine dimethylhydrolase 1 in the proliferative effect of Astragali radix on cardiac cells. | J Ethnopharmacol | 2011 |
| 20225273 | CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression. | J Cell Biochem | 2010 |
| 20547241 | Transcriptional regulation and functional implication of the grass carp CITED1 (gcCITED1) in the negative regulation of HIF-1. | Int J Biochem Cell Biol | 2010 |
| 19883516 | Functional characterization of two CITED3 homologs (gcCITED3a and gcCITED3b) in the hypoxia-tolerant grass carp, Ctenopharyngodon idellus. | BMC Mol Biol | 2009 |
| 18945501 | Enhancement of hypoxia-induced gene expression in fish liver by the aryl hydrocarbon receptor (AhR) ligand, benzo[a]pyrene (BaP). | Aquat Toxicol | 2008 |
| 17382971 | Characterization of a hypoxia-responsive leptin receptor (omLepR(L)) cDNA from the marine medaka (Oryzias melastigma). | Mar Pollut Bull | 2007 |
| 16623959 | Cloning and expression analysis of two distinct HIF-alpha isoforms--gcHIF-1alpha and gcHIF-4alpha--from the hypoxia-tolerant grass carp, Ctenopharyngodon idellus. | BMC Mol Biol | 2006 |
| 16961934 | Hypoxia induces telomerase reverse transcriptase (TERT) gene expression in non-tumor fish tissues in vivo: the marine medaka (Oryzias melastigma) model. | BMC Mol Biol | 2006 |